Back |
home / stock / imlff / imlff message board
Subject | By | Source | When |
---|---|---|---|
Huge squeeze in play here, 800,000 float and | dinogreeves | investorshub | 11/02/2022 10:38:38 PM |
$INM InMed Pharmaceuticals Inc | mick | investorshub | 10/23/2022 6:40:00 PM |
30x float traded today another 75 percent tomorrow | akamaii | investorshub | 09/12/2022 10:42:47 PM |
Held my 100 profit will be 25 tomorrow | akamaii | investorshub | 09/12/2022 8:04:06 PM |
Major pump is coming thinking this will run | akamaii | investorshub | 09/10/2022 3:27:22 PM |
InMed Announces Share Consolidation to Meet Nasdaq Listing | mick | investorshub | 08/31/2022 10:45:35 PM |
$INM InMed Pharmaceuticals Inc | mick | investorshub | 08/31/2022 10:45:07 PM |
$WOLF TICKETS 2022 | NickDiaz209 | investorshub | 07/19/2022 9:41:52 AM |
$INM InMed Pharmaceuticals Inc | mick | investorshub | 07/17/2022 9:34:12 PM |
InMed Pharmaceutical ($INM) | mick | investorshub | 06/04/2022 7:51:37 PM |
InMed Pharmaceutical ($INM) | mick | investorshub | 05/01/2022 7:31:37 PM |
InMed Pharmaceutical ($INM) | mick | investorshub | 03/12/2022 8:12:29 PM |
This is our time. This time right now. | Aladdin80 | investorshub | 02/24/2022 3:36:41 PM |
News, Short Squeeze, Breakout and More Instantly...
InMed Pharmaceuticals Inc. Company Name:
IMLFF Stock Symbol:
OTCMKTS Market:
InMed Announces Closing of US$4.5 Million Private Placement PR Newswire VANCOUVER, BC , Feb. 16 , 2021 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (Nasdaq: INM) (TSX: IN), a clinical-stage pharmaceutical company developing medicat...
InMed Pharmaceuticals Reports Second Quarter Fiscal 2021 Financial Results Canada NewsWire VANCOUVER, BC , Feb. 11, 2021 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage pharmaceutical company develo...
InMed Pharmaceuticals to Report Second Quarter Fiscal 2021 Financial Results Canada NewsWire VANCOUVER, BC , Feb. 5, 2021 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage pharmaceutical company developing...